低分子肝素钙联合依达拉奉治疗进展性脑梗死的疗效分析

目的 探讨低分子肝素钙联合依达拉奉治疗进展性脑梗死临床效果。方法 我院2008年3月~2009年10月收治进展性脑梗死患者49例,随机分为对照组和治疗组。对照组给予常规治疗,治疗组在常规治疗基础上给予低分子肝素钙和依达拉奉。结果 两组患者治疗后神经功能缺损评分均低于治疗前,治疗后治疗组功能缺损评分显著低于对照组;对照组总有效率80.0%,治疗组总有效率93.1%,两组总有效率比较差异有显著性。结论 低分子肝素钙与依达拉奉联用有效改善进展性脑梗死预后,值得临床推广。

Curative Effect of Low Molecular Heparin Calcium Combined with Edaravone for Progressive Cerebral Infarction

Objective To discuss the curative effect of low molecular heparin calcium combined with edarvone for progressive cerebral infarction. Methods We selected 49 of patients with cases of progressive cerebral infarction and divided them into treatment group and control group. Both groups received conventional therapy,and low molecular heparin calcium combined with edaravone was added to the treatment i＇group, Results The neurological deficit score of the two groups was lower than that before treatment,and the score was significantly lower in the trcatmen~ group than that of the control group. The total effective rate was 80.00% in the control group and 93.1% in the treatment group. Conclusion Low molecular heparin calcium in conjunction with the use of edaravone can effectively improve prognosis of progressive cerebral infarction,worthy to be popularized.